The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FOREX-Risk currencies gain as Trump gives way to transition, Yellen emerges as Biden pick

Tue, 24th Nov 2020 03:55

* Yellen seen as supportive of monetary and fiscal stimulus

* Trump gives nod to transition process, boosting risk
appetite

*

* Graphic: World FX rates in 2020 https://tmsnrt.rs/2RBWI5E

By Hideyuki Sano

TOKYO, Nov 24 (Reuters) - Risk-sensitive currencies gained
on Tuesday as investors breathed easier after U.S. President
Donald Trump accepted the start of a transition to a Biden
administration, that is expected to include former Federal
Reserve Chair Janet Yellen as Treasury secretary.

Trump gave the head of the General Services Administration
the go-ahead to proceed with a transition to a government led by
President-elect Joe Biden despite plans to continue with legal
challenges.

Democratic allies to the Biden campaign said Yellen is
expected to be nominated to become Treasury Secretary,
heartening investors as she has called for increased government
spending to lift the economy out of a coronavirus induced
recession.

"One thing is for sure and that is there is unlikely to be
as many Fed-Treasury spats," said Chris Rupkey, chief financial
economist at MUFG Union Bank in New York.

"Those Fed lending facilities for municipal funding, the
corporate bond market and Main Street will be coming back
quickly after the December 31 expiration date."

Last week U.S. Treasury Secretary Steven Mnuchin let some of
the Fed's lending programmes expire at the end of this year,
opening a feud with the Fed, which said those emergency
facilities are important to support the economy.

The Australian dollar ticked up 0.4% to $0.7313
while emerging market currencies such as the Mexican peso
and the South African rand also gained about 0.4%
.

The New Zealand dollar soared as much as 0.9% to
scale a two-year high of $0.6985 also after the country's
government sought advice from the Reserve Bank of New Zealand
(RBNZ) on how it could help stabilise property prices, prompting
investors to unwind wagers of more monetary easing.

The dollar held firmer against the safe-haven yen and the
euro, after IHS Markit's U.S. manufacturing and services sector
purchasing managers' indexes (PMI) both topped even the most
optimistic forecasts in a Reuters poll.

While the U.S. PMI is usually not a big market mover, the
reading made a sharp contrast with less inspiring figures from
Europe published several hours earlier, helping the dollar to
gain against the euro, traders said.

The safe-haven yen traded at 104.49 per dollar,
having slipped about 0.6% overnight while the euro slipped to
$1.1844 on Monday.

That helped to lift the dollar index to 92.463, off Monday's
low of 92.013, its lowest since Sept. 1.

"The apparent strength of the U.S. data was favourable for
the dollar," said Kyosuke Suzuki, director of forex at Societe
Generale.

But Suzuki added that, despite its latest gains, the
dollar's downtrend is likely to continue given the U.S. is
running huge fiscal and trade deficits.

The U.S. currency's safe-haven appeal was also dented after
AstraZeneca further lifted investors' appetite for risk
by saying its COVID-19 vaccine could be about 90% effective and
it would prepare to submit data to authorities around the world
that have a framework for conditional or early approval.

The British pound held firm near a 12-week high against the
dollar and six-month high versus the euro, propped up by bets
Britain and the European Union would clinch a Brexit trade deal.

London and Brussels this week continue their negotiations to
agree a deal on their future trading relationship, though time
is now running very short as Britain's post-Brexit transition
period ends in fewer than six weeks.

The pound stood at $1.3330, having hit a high of
$1.3396 on Monday. Against the euro, it traded at 0.8887 to the
euro, near its six-month high touched about two
weeks ago.
(Reporting by Hideyuki Sano
Editing by Shri Navaratnam & Simon Cameron-Moore)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.